Response to the Letter to the Editors by Raschi et al: "Antipsychotics and Drug-Associated Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies"
J Clin Psychopharmacol
.
2023 Jan-Feb;43(1):83-84.
doi: 10.1097/JCP.0000000000001648.
Authors
René Zeiss
1
,
Maximilian Gahr
Affiliation
1
University of Ulm, Ulm, Germany rene.zeiss@uni-ulm.de.
PMID:
36441006
DOI:
10.1097/JCP.0000000000001648
No abstract available
Publication types
Letter
Comment
MeSH terms
Adverse Drug Reaction Reporting Systems
Antipsychotic Agents* / adverse effects
Humans
Pharmacovigilance
Risk Factors
Substances
Antipsychotic Agents